Stay updated on Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.

Latest updates to the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page
- Check5 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.4%
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check27 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.6%
- Check41 days agoChange DetectedThe page has updated its event dates and removed references to the Nebraska Medicine Heartland Hematology Oncology, while adding information about the Fred and Pamela Buffett Cancer Center in Kearney.SummaryDifference0.4%
- Check56 days agoChange DetectedThe page has updated the name of the medical center to 'MaineHealth Maine Medical Center- Scarborough' and has revised the version number to v2.15.2. Additionally, several older dates and the previous version number v2.15.0 have been removed.SummaryDifference0.3%
- Check70 days agoChange DetectedThe page has been updated to include new identifiers and collaborators related to clinical trials for recurrent ovarian and fallopian tube cancers, while significant details about the trial's objectives and treatment protocols have been removed.SummaryDifference40%
Stay in the know with updates to Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.